| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/05/2004 | US20040023335 IL-17 like molecules and uses thereof |
| 02/05/2004 | US20040023334 Comprises lactoferrin fusion protein for diagnosis, prevention treatment and prognosis of nervous system, respiratory, cardiovascular and/or reproductive system disorders |
| 02/05/2004 | US20040023333 Production of recombinant blood clotting factors in human cell lines |
| 02/05/2004 | US20040023332 Genes of il-12p40 subunit mutated for improving the activity of il-12 and thereof for dna vaccine adjuvant |
| 02/05/2004 | US20040023331 Comprises membrane protein for diagnosis, prevention and treatment cell proliferative disorders; tumor detection |
| 02/05/2004 | US20040023328 Comprises peptide sequences associatead with potassium channel proteins for diagnosing and treating tumors and vessicle transport disorders |
| 02/05/2004 | US20040023327 Using site directed mutagenesis to cause nucleotide sequences alterations in target protein; polypeptide engineering |
| 02/05/2004 | US20040023325 Comprises genetically engineered outer surface protein for use in treatment and prevention of lyme disease; genetic vaccines |
| 02/05/2004 | US20040023323 Novel cytokine receptors and nucleic acids encoding the same |
| 02/05/2004 | US20040023322 Preparing bone morphogenic proteins (BMP) in mammalian culture for use in models of bone formation |
| 02/05/2004 | US20040023321 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptides; cancer diagnosis |
| 02/05/2004 | US20040023315 Transgenic yeast cells coding membrane receptor proteins for diagnosis and treatment of pancreatitis, pancreatic cancer, gastrointestinal disorders and irritable bowel disease |
| 02/05/2004 | US20040023314 Identifying cells that will differentiate into metastatic cancer via presence of increased concentration of aberrant cell adhesion molecule and decrease in cellular matrix formation |
| 02/05/2004 | US20040023307 DNA encoding a novel RG1 polypeptide |
| 02/05/2004 | US20040023297 Modulation of tetraspanin function |
| 02/05/2004 | US20040023294 G-protein coupled receptors |
| 02/05/2004 | US20040023291 Comprises insect polypeptide for use in hemolysis and immunosuppression; immunotherapy |
| 02/05/2004 | US20040023283 Comprises nucleotide sequences coding polypeptide for diagnosis, prevention and treatment of immunological, hematopoietic and inflammatory disorders |
| 02/05/2004 | US20040023281 Production of lysosomal enzymes in plants by transient expression |
| 02/05/2004 | US20040023280 Using presence of mutation in gene coding bone morphogenic protein receptor-2 protein (BMPR-II) to diagnose hereditary lung disorders |
| 02/05/2004 | US20040023278 Sialoadhesin family member-2 (SAF-2) |
| 02/05/2004 | US20040023276 LXR-ligand induced genes and proteins |
| 02/05/2004 | US20040023270 Novel plant agglutinin gene |
| 02/05/2004 | US20040023268 Comprises membrane proteins for diagnosing, preventing and treating cell proliferative, nervous system, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders; drug screening; mimetics |
| 02/05/2004 | US20040023267 Comprises nucleotide sequences coding cancer associated proteins (CAP) for diagnosis, prevention and treatment of tumors |
| 02/05/2004 | US20040023263 Method of testing for allergic diseases |
| 02/05/2004 | US20040023260 29 human secreted proteins |
| 02/05/2004 | US20040023259 Comprises proteins for treating and preventing cell proliferation disorders; antitumor agents |
| 02/05/2004 | US20040023257 Comprises nucleotide sequences coding proteolytic enzymes for increasing flavor in food, promoting microbiocidal activity, modifying and deprotecting chemical intermediates, synthesis and hydrolysis of cephalosporins |
| 02/05/2004 | US20040023255 Motor proteins and methods for their use |
| 02/05/2004 | US20040023252 G-protein coupled receptors |
| 02/05/2004 | US20040023251 Comprises cell cycle and mitosis associated polypeptides (CCMAM) for diagnosis, treatment and prevention of cell proliferative, developmental and immunological disorders |
| 02/05/2004 | US20040023244 Receptors |
| 02/05/2004 | US20040023241 Comprises novel proteins for diagnosis and treatment of cardiomyopathy, atherosclerosis, hypertension, metabolic, skin and tumor disorders |
| 02/05/2004 | US20040023234 BSND (Barttin) protein and nucleic acids encoding the BSND protein; assays for the detection of BSND and barttin polymorphisms and mutations associated with disease states; Bartter syndrome (aBS) |
| 02/05/2004 | US20040023233 DNA sequences found in the regulatory region of cytoprotective genes that are cytoprotective response elements |
| 02/05/2004 | US20040023230 Chemically modified genomic sequences of genes associated with pharmacogenomics, oligonucleotides and/or PNA-oligomers for detecting the cytosine methylation state of these genes which are directed against the sequence |
| 02/05/2004 | US20040023219 Novel prostate cancer genes |
| 02/05/2004 | US20040023215 Methods and compositions employing the nucleic acids, polypeptides or peptides, antibodies, and/or ligands for use in diagnostics and therapeutics for asthma and other diseases |
| 02/05/2004 | US20040023205 Method of recovering a nucleic acid encoding a proteinaceous binding domain which binds a target material |
| 02/05/2004 | US20040023204 Peptides which enhance transport across tissues and methods of identifying and using the same |
| 02/05/2004 | US20040023203 Heterologous stimulus-gated ion channels and methods of using same |
| 02/05/2004 | US20040022870 Immunogenic TLP composition |
| 02/05/2004 | US20040022811 For use in diagnosis, prophylaxis |
| 02/05/2004 | US20040022809 Cold-adapted equine influenza viruses |
| 02/05/2004 | US20040022805 Useful for incorporation into the DNA vaccine vectors; for prophylaxis and therapy of malaria |
| 02/05/2004 | US20040022804 Administering protein Q or a variant thereof containing modifications or substitutions of preserved amino acid residues, protein Q or variant thereof being optionally combined with complete or fragmented protein LiHsp70 and |
| 02/05/2004 | US20040022803 Base205 polypeptides and polynucleotides therefor |
| 02/05/2004 | US20040022802 Surface proteins of Leptospira |
| 02/05/2004 | US20040022801 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/05/2004 | US20040022799 Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
| 02/05/2004 | US20040022797 Eta-1 gene and methods for use |
| 02/05/2004 | US20040022795 Protective antigens for the control of Ixodes species infestations |
| 02/05/2004 | US20040022790 CNS neurite outgrowth modulators, and compositions, cells and methods embodying and using same |
| 02/05/2004 | US20040022787 Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID |
| 02/05/2004 | US20040022786 For immunotherapy and diagnosis of disorders associated with TLR9 or TLR10 protein-expressing cells, such as B-cell lymphoma, T cell lymphoma, acute myeloid leukemia, Hodgkin's disease, B cell leukemia, chronic lymphocytic leukemia |
| 02/05/2004 | US20040022785 Expression of herstatin, an alternative HER-2/neu product, in cells that express either p185HER-2 or the EGF receptor inhibits receptor activity and cell growth |
| 02/05/2004 | US20040022783 Binding agents to CD23 |
| 02/05/2004 | US20040022781 Proteins and nucleic acids encoding same |
| 02/05/2004 | US20040022779 Method for identifying apoptosis-modified proteins |
| 02/05/2004 | US20040022777 Fragments and antagonists of heat shock protein 60 |
| 02/05/2004 | US20040022776 Provides larvicide activity, against Dipteral insects; shelf life |
| 02/05/2004 | US20040022773 Obtaining a biological sample from a mammal; contacting the biological sample with a medium comprising NK-92 or modified NK-92 natural killer cells |
| 02/05/2004 | US20040022772 Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth |
| 02/05/2004 | US20040022769 To induce killing of tumor cells and concomitantly mobilize differentiate, activate and attract dendritic cells through the expression of cytokines and dendritic cell chemoattractants |
| 02/05/2004 | US20040022767 Novel cytokine designated elk ligand |
| 02/05/2004 | US20040022766 Administering by subretinal injection an effective amount of recombinant adeno-associated virus carrying a nucleic acid sequence encoding normal gene under the control of promoter sequence which expresses the product of gene in ocular cells |
| 02/05/2004 | US20040022763 Human recombinant beta-interferon with improved solubility |
| 02/05/2004 | US20040022760 Administering Flt3-ligand to a subject; optionally administering an auxiliary molecule; administering a vaccine to the subject, wherein the vaccine comprises an antigen and an adjuvant |
| 02/05/2004 | US20040022731 In vivo imaging of apoptosis |
| 02/05/2004 | DE10233064A1 gM-negative EHV-Mutanten ohne heterologe Elemente gM-negative EHV mutants without heterologous elements |
| 02/05/2004 | DE10232773A1 Proteins of the ubiquitin proteosome metabolic pathway, useful as targets for identifying fungicides for use in plant protection, also new nucleic acids, proteins and fungicides |
| 02/05/2004 | DE10232483A1 Transgene Expressionskonstrukte und Verfahren zum Erhöhen des Vitamin E-Gehaltes in pflanzlichen Organismen The transgenic expression constructs and methods for increasing the vitamin E content in plant organisms |
| 02/05/2004 | DE10228218A1 New nucleic acid for polypeptide containing trimerization domain and epitopes, useful for vaccination against e.g. infectious disease or tumors, improves peptide antigenicity |
| 02/05/2004 | CA2727782A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 02/05/2004 | CA2531779A1 Multi-reporter gene model for toxicological screening |
| 02/05/2004 | CA2494098A1 Methods of using non-human animal apoliprotein a-i protein |
| 02/05/2004 | CA2493590A1 Auto-stimulating cells and method for making and using the same |
| 02/05/2004 | CA2493347A1 Novel albumins |
| 02/05/2004 | CA2493306A1 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 02/05/2004 | CA2493142A1 Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers |
| 02/05/2004 | CA2492977A1 Expression receptors with 7 transmembrane domains in baculovirus-insect cell system |
| 02/05/2004 | CA2492442A1 Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (pacap) |
| 02/05/2004 | CA2492333A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 02/05/2004 | CA2492295A1 Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion |
| 02/05/2004 | CA2488863A1 Identification of a novel bitter taste receptor, t2r76 |
| 02/05/2004 | CA2488348A1 Long lasting natriuretic peptide derivatives |
| 02/05/2004 | CA2485092A1 Mammalian genes involved in viral infection and tumor suppression |
| 02/05/2004 | CA2484941A1 Antigens encoded by alternative reading frame from pathogenic viruses |
| 02/04/2004 | EP1387173A1 Method for improved diagnosis of cervical lesions based on detection of INK4a gene products |
| 02/04/2004 | EP1386967A2 DNA Encoding Mammalian phosphodiesterases |
| 02/04/2004 | EP1386966A1 Method for the expression of unknown environmental DNA into adapted host cells |
| 02/04/2004 | EP1386965A1 Novel potential-dependent cation channel protein |
| 02/04/2004 | EP1386963A1 Peptides having cytotoxicity inhibitory activity and method of screening these peptides having cytotoxicity inhibitory activity |
| 02/04/2004 | EP1386933A1 Cytokine antagonists and agonists |
| 02/04/2004 | EP1386932A1 Improved humanized immunoglobulins |
| 02/04/2004 | EP1386931A1 Human neurotrimin homologue |
| 02/04/2004 | EP1386930A1 Derivatives of exendin |
| 02/04/2004 | EP1386929A1 Peptides associated with tumors and uses related thereto |
| 02/04/2004 | EP1386928A1 A frog skin antibacterial peptide derivative |